Randomized Phase 2 trial initiated for agenT-797 in severe acute lung injury and respiratory distress, with preliminary data ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

WATERVILLE — Thomas College announces a new master’s program in clinical mental health counseling set to launch in fall 2026 that will help address ...

Northeast Community College’s paramedicine program continues to prepare students for high-demand careers in emergency medical ...

Health systems address food insecurity clinical risk by embedding nutrition programs and RDN-led interventions into patient care workflows.

Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center registrational trial for SENTI-202, building off the strong Phase 1 clinical results demonstrating deep a ...

A 21-element recovery program for children undergoing gastrointestinal surgery reduced opioid use during hospitalization by ...

Special Report: Micro-X has reported a milestone-heavy March quarter, with progress across its Head CT clinical program, ...

Dr. Marty Makary, the FDA’s commissioner, said the program targets “dead time,” or about half the time between the launch of phase one clinical trials and applications to the FDA at the end of the ...

Trump's One Big Beautiful Bill says nurses are no longer professionals. The impacts to nursing and public health are massive.

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...